These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18463601)

  • 1. Novel spiroannulated 3-benzofuranones. Synthesis and inhibition of the human peptidyl prolyl cis/trans isomerase Pin1.
    Braun M; Hessamian-Alinejad A; de Lacroix BF; Alvarez BH; Fischer G
    Molecules; 2008 Apr; 13(4):995-1003. PubMed ID: 18463601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1.
    Daum S; Erdmann F; Fischer G; Féaux de Lacroix B; Hessamian-Alinejad A; Houben S; Frank W; Braun M
    Angew Chem Int Ed Engl; 2006 Nov; 45(44):7454-8. PubMed ID: 17048295
    [No Abstract]   [Full Text] [Related]  

  • 3. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
    Jiang B; Pei D
    J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
    Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
    J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
    Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
    Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
    Marsolier J; Weitzman JB
    Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of novel human Pin1 inhibitors (I).
    Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
    Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
    Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesis.
    Fan X; He H; Li J; Luo G; Zheng Y; Zhou JK; He J; Pu W; Zhao Y
    Bioorg Med Chem; 2019 Jun; 27(11):2235-2244. PubMed ID: 31027708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
    Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
    J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
    Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
    Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
    Stifani S
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H, 13C and 15N backbone resonance assignment of the peptidyl-prolyl cis-trans isomerase Pin1.
    Jacobs DM; Saxena K; Grimme S; Vogtherr M; Pescatore B; Langer T; Elshorst B; Fiebig KM
    J Biomol NMR; 2002 Jun; 23(2):163-4. PubMed ID: 12153046
    [No Abstract]   [Full Text] [Related]  

  • 16. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
    Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of protein transduction domain-fused peptidyl prolyl cis/trans isomerase Pin1.
    Ohashi T; Teshima S; Hidaka M; Uchida T
    Biosci Biotechnol Biochem; 2010; 74(10):2067-70. PubMed ID: 20944414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent synthesis of alpha-ketoamide inhibitors of Pin1.
    Xu GG; Etzkorn FA
    Org Lett; 2010 Feb; 12(4):696-9. PubMed ID: 20102178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
    Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphine-containing Lewis base catalyzed cyclization of benzofuranone type electron-deficient alkenes with allenoates: a facile synthesis of spirocyclic benzofuranones.
    Li X; Wang F; Dong N; Cheng JP
    Org Biomol Chem; 2013 Mar; 11(9):1451-5. PubMed ID: 23344672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.